Company intelligence / Profile preview

BOE Regenerative Medicine Technology

Beijing, Beijing Shi, China
Ownership
Private
Development stage
Other
01

Overview

BOE Regenerative Medicine Technology has developed a human umbilical cord mesenchymal stem cell membrane product that was approved for clinical use in China for the treatment of low ejection fraction coronary heart disease after CABG. This is the first clinically approved stem cell membrane new drug in China. The company also works on immune cell therapies and storage solutions for both stem cells and immune cells, collaborating with hospitals to advance clinical applications in tumor prevention and other regenerative medicine areas[1][2][7].

Therapeutic areas
Cardiovascular
Modalities
Mesenchymal stem cell therapyStem cell membrane therapyCell therapy
Industry
Biotech
02

Drug pipeline

1 asset

human umbilical cord mesenchymal stem cell sheet

Unknown
03

Partnerships

Collaborates with hospitals for advancing clinical applications, especially in tumor prevention/treatment and regenerative medicine research

Beyond the preview

Go deeper on BOE Regenerative Medicine Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BOE Regenerative Medicine Technology.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call